India allows limited exports of anti-malaria drug after Trump warns of retaliation – By Reuters Staff (CNBC) / April 7 2020
- India, the world’s main supplier of generic drugs, said it will allow limited exports of hydroxychloroquine.
- U.S. President Donald Trump has touted the anti-malaria drug as a potential weapon in the fight against the coronavirus.
- Use of hydroxychloroquine has soared as the U.S. has quickly become the epicentre of the pandemic, though doctors prescribing it have no idea whether it works.
India, the world’s main supplier of generic drugs, said on Tuesday it will allow limited exports of the anti-malaria drug hydroxychloroquine that U.S. President Donald Trump has touted as a potential weapon in the fight against the coronavirus.
The Indian government had put a hold on exports of hydroxychloroquine as well as on the pain reliever, paracetamol, saying stocks were depleting because of the hit to global supply chains after the coronavirus emerged in China late last year.
India’s Prime Minister Narendra Modi (L) attends a meeting with US President Donald Trump during the G20 Osaka Summit in Osaka on June 28, 2019.
Brendan Smialowski | AFP | Getty Images
But Trump spoke to Prime Minister Narendra Modi over the weekend seeking supplies and on Monday said India may face retaliation if it didn’t withdraw the ban on exports.
India’s neighbours, including Nepal, have also sought the anti-malaria drug.
Continue to article: https://www.cnbc.com/2020/04/07/india-allows-limited-exports-of-anti-malaria-drug-after-trump-warns-of-retaliation.html
